Strategic initiative: Registers and biobanks in transition
Accelerating the use of big data for health care
Biobanks and health data registers can give unparalleled insights, and Scandinavian and Estonian biobanks and health data collections are true goldmines. Access to qualitative sample and data collections can be very valuable tools in R&D, paving the way for new medicines, treatments and medical products. Access can, however, be perceived complicated.
Through the “Biobanks and Registers in Transition” strategic initiative, EIT Health Scandinavia aims to accelerate the use of big data, biobanks and health data registries in development of new healthcare solutions, through helping the EIT Health Partners in their R&D ambitions. The initiative seeks to address several issues which hinders the Partners from leveraging the Scandinavian and Estonian assets in biobanks and health data collections, including simplifying access, in order to gain improvements for R&D and to implement new innovations faster into the market.
Biobanks and quality registries are valuable tools for product development and validation, molecularly stratified clinical trials, follow-up of current healthcare outcomes, predicting impact of new products and services, including cost-benefit analysis, and more. Access to qualitative sample and data collections can give unparalleled insights, paving the way for new medicines, treatments and medical products. EIT Health is working to support its Partners in simplifying access to biobanks and quality registries, and to help them leverage the assets available in Denmark, Estonia and Sweden.
Project Manager: Ulrika Zagai
Ulrika is a biologist with a PhD in Lung Medicine and Immunology she has moved from PCR and cell culture assays to collecting data in big cohort studies. For the last 11 years she has been working at Karolinska Institutet. Lately she has worked as project manager in the Swedish Twin Registry, the largest of its kind in the world, as well as in a research group as a lab manager, focusing on microbiome and cancer, combining epidemiology and basic science.
The initiative’s steering group consists of:
- Per Matsson (Chairman), ThermoFisher Scientific
- Eva Tiensuu Jansson, Uppsala University
- Anders Gustafsson, Karolinska Institutet
- Lili Milani, University of Tartu
- Henning Langberg, Copenhagen Healthtech cluster
- Gavyn Edmunds, Region Skåne
The strategic initiative Registers and Biobanks in Transition seeks to address several issues, with the overall goal of simplifying access to biobanks and quality registries in order to gain improvements for R&D and to implement new innovations faster into the market, in particular by leveraging the Scandinavian and Estonian assets in biobanks and data registers.
The initiative is an outcome of discussions in the 2018 EIT Health ThinkTank Round Table, in particular one held 13 August 2018 in Stockholm, during which it was noted that there are different rules in different countries impacting how biobanks and registers act today. Based on this discussion EIT Health chose to address the situation of access to registers and biobanks, starting with a focus on the situation in Sweden, Estonia and Denmark. This initiative is piloted in Scandinavia, but we expect to expand it all over the Europe.
The initiative focuses on industry needs, setting up dialogues with industry representatives, mapping their needs, and establishing ways of providing information, encouraging use of biobanks, and strengthening collaboration between industry and biobanks/register. We foresee that the strategic activity will support the EIT Health Partners by saving time and simplifying access to biobanks and quality register.
- Web site acting as a portal to ease access to biobanks and register. The Biobanks & Health Data Information Hub can be found here.
- Mapping of current projects involving biobanks and registries and ways to improve access.
- Face-to-face meetings with pharma companies.
- Co-development of Digital Sandbox call, with EIT Health Accelerator, for projects to increase use of biobanks/registers.
- A matchmaking event Biobanks and Registers – your springboard to innovation – was held in Stockholm in 2019 and a followup event is planned for in October 2020.
For EIT Health Partners and other healthcare innovators:
- Fragmented information from biobanks and registries made easy to find on one site.
- Increased quality of innovations using big data.
- Easy validation of developed products and disease prediction algorithms, or stratification of target group of clinical trials.
- Identifying challenges and needs.
- Increased exposure.
- Knowledge of industry needs.
- Bringing industry closer to biobanks.
For patients and the healthcare system:
- Biobanks and registries offer a wealth of possibilities to advance healthcare through evidence-based approaches.
Why this is an EIT Health project
We aim to create soft infrastructure to facilitate use of big data, health registries and biobanks primarily among EIT Health Partners. Value for EIT Health:
- A showcase of how to support usage of biobanks and registries in developing healthcare solutions.
- Testing the working model in one region/CLC and multiplying all over the Europe.
- Increased quality of EIT Health project proposals by using big data.
- Better quality of projects, improved chances that the project outcomes will be adopted by the market.
- Increased awareness and use of biobank assets among EIT Health Partners.
Biobanks & Health Data Information Hub
Access biobanks and health data registers. We make it easier to establish productive collaborations that will help shape the future of healthcare and translational medicine.